Clinical Dosage:
●Obesity trials use 1.2–2.4 mg/week via subcutaneous injection.
Bodybuilding Protocol:
●Beginner: 0.6 mg/week (to assess tolerance).
●Intermediate: 1.2 mg/week.
●Advanced: 2.4 mg/week (monitor for nausea).
Cycle Length: 8–16 weeks, aligned with cutting phases. Avoid prolonged use due to limited long-term data.
Email: amyraws195@gmail.com
Whatsapp/Telegram: +852 56445864
https://www.giantrawsource.com/peptides/peptides-cagrilintide-5mg-vial.html
